<?xml version="1.0" encoding="UTF-8"?>
<p>Antiviral therapy may be of value although a recent trial of lopinivar/ritonavir proved to be negative when used as a single agent.(
 <xref rid="R19" ref-type="bibr">19</xref>) Other agents that are being studied are remdesivir, an agent devised for the therapy of Ebola, and there is promising evidence that this agent, which binds to RNA-dependent RNA polymerase and acts as an RNA-chain terminator, may be of value in treating CoVID-19 as well. There are currently four ongoing clinical trials utilizing this agent.(
 <xref rid="R20" ref-type="bibr">20</xref>,
 <xref rid="R21" ref-type="bibr">21</xref>)
</p>
